| トルコ | オーストリア | スペイン | |
| 肝動脈化学塞栓療法 | から $7,500 | から $16,000 | から $12,000 |
ジャウメ・カプデビラ博士は、消化管および膵臓癌の治療を専門とする高度な資格を有する医師であり、レリダ大学にて医学・外科学の学位を取得し、サンタ・クレウ・イ・サント・パウ病院にて腫瘍内科の専門研修を修了しました。同博士はEORTC、ESMO、ENETS、ASCO、GEMCAD、TTD、GETHIを含む複数の専門職団体の会員です。
Choosing Spain for TACE offers access to the global gold standard in liver cancer management. As the birthplace of the Barcelona Clinic Liver Cancer staging system, Spain provides unmatched clinical expertise, JCI-accredited facilities, and advanced interventional radiology at 57% lower cost than in the US.
Bookimed Expert Insight: Spain’s oncology market is uniquely mature, with Clinica Universidad de Navarra being the first in the country to secure JCI accreditation. This long-standing commitment to international standards means their care protocols for complex procedures like TACE are exceptionally refined for foreign patients.
Patient Consensus: Patients value the significant cost savings on liver treatments and find the lower cost of living in Spain makes staying for extended recovery much more affordable.